Aparna Chauhan, Mufiza Farid-Kapadia, Hersh Goel, Stephen J. Valerio, Neel Vaidya. "Characterization of the real-world first line (1L) use of single dose tremelimumab regular interval durvalumab (STRIDE), for treatment of unresectable hepatocellular carcinoma (uHCC), using two electronic medical record (EMR) databases.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.4_suppl.534